Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ACAD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ACAD investment potential.

What is ACAD stock price today?

Get real-time ACAD stock price, historical data, and price charts on Financhill. Track ACAD performance with our advanced analysis tools.

Is ACAD a good investment?

Evaluate ACAD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ACAD stock?

To buy ACAD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ACAD?

View detailed market capitalization data and company valuation metrics for ACAD on our comprehensive analysis page.

What is the P/E ratio of ACAD?

Use our fundamental analysis tools to view ACAD P/E ratio and compare valuation metrics with industry peers.

What are ACAD earnings?

View ACAD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

ACADIA Pharmaceuticals, Inc. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

ACAD
ACADIA Pharmaceuticals, Inc.

Last Price:

$27.15

Seasonality Move:

12.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

ACADIA Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, ACADIA Pharmaceuticals, Inc. has on average historically risen by 41.4% based on the past 21 years of stock performance.
ACADIA Pharmaceuticals, Inc. has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Is ACADIA Pharmaceuticals, Inc. Stock Undervalued?

The current ACADIA Pharmaceuticals, Inc. [ACAD] share price is $27.15. The Score for ACAD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
ACAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ACADIA Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, ACADIA Pharmaceuticals, Inc. has on average historically risen by 41.4% based on the past 21 years of stock performance.

ACADIA Pharmaceuticals, Inc. Stock Rating

Buy

ACADIA Pharmaceuticals, Inc. (ACAD) is a Buy

Is ACADIA Pharmaceuticals, Inc. overpriced?

ACADIA Pharmaceuticals, Inc. has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

ACADIA Pharmaceuticals, Inc. Stock Price History

Is ACAD stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

acadia.com

52-Week Data

52-Week High:

27.73

52-Week Low:

13.40

Prediction Charts

Market Cap:

4.6B

Price in USD:

27.15

Volume:

1.4M

Beta:

1.79

Technical Analysis

SMA50:

23.20

SMA100:

23.66

SMA200:

21.27

52-Wk Change:

57.3%

Stock Predictions

Is ACADIA Pharmaceuticals, Inc. stock public?

Yes, ACADIA Pharmaceuticals, Inc. is a publicly traded company.
What is the ACADIA Pharmaceuticals, Inc. stock quote today?

The ACADIA Pharmaceuticals, Inc. stock price is 27.15 USD today.
How to buy ACADIA Pharmaceuticals, Inc. stock online?

You can buy ACADIA Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-24	23.57	23.90	23.93	23.10
Nov-25	24.07	24.39	24.66	24.00
Nov-26	24.22	24.81	25.20	24.20
Nov-28	24.93	25.04	25.12	24.56
Dec-1	24.74	24.85	25.21	24.59
Dec-2	25.24	25.43	25.68	24.87
Dec-3	25.51	25.88	26.12	25.29
Dec-4	25.57	26.55	26.76	25.40
Dec-5	26.75	27.44	27.61	26.74
Dec-8	27.67	26.76	27.73	26.60
Dec-9	26.76	26.89	27.67	26.70
Dec-10	26.87	26.81	27.07	26.55
Dec-11	26.67	26.68	26.97	26.38
Dec-12	26.75	27.15	27.28	26.42

ACADIA Pharmaceuticals, Inc. Earnings

ACADIA Pharmaceuticals, Inc. Earnings Report: Per Share ACADIA Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

ACADIA Pharmaceuticals, Inc. Forecast Revenue Growth

ACADIA Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for ACADIA Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.00 per share.

* ACADIA Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.